Prognostic value of CYFRA 21.1 in malignant mesothelioma: A brief report of the randomized phase II trial NVALT19

To the Editor:

Source: Lung Cancer - September 24, 2021 Category: Cancer & Oncology Authors: Cornedine J. de Gooijer, Vincent van der Noort, Daan van den Broek, Paul Baas, Jacobus A. Burgers Source Type: research